Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Eagan

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reports|March 1, 1986
Phase II trial of diaziquone in malignant mesotheliomaR T Eagan, S Frytak, R L Richardson, et al.
American Journal of Clinical Oncology|February 1, 1987
Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trialR T Eagan, T M Therneau, J Rubin, et al.
Cancer Treatment Reports|October 1, 1987
Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancerR T Eagan, C Ruud, R E Lee, et al.
American Journal of Clinical Oncology|February 1, 1986
Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|August 1, 1982
Phase II study on DON in patients with previously treated advanced lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Cancer Treatment Reports|August 1, 1980
Early clinical trial of a 1-day intermittent schedule for pentamethylmelamineR T Eagan, E T Creagan, J Rubin, et al.
American Journal of Clinical Oncology|October 1, 1983
Preliminary communication--treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ;NSC-182986)R T Eagan, R P Dinapoli, R C Hermann, et al.
Cancer Chemotherapy Reports|March 1, 1975
Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanomaD L Ahmann, R G Hahn, H F Bisel, et al.
Cancer Treatment Reports|February 1, 1984
Carmustine and Baker's antifol combination chemotherapy for primary brain tumors progressive after irradiation and chemotherapyR T Eagan, R P Dinapoli, R C Hermann, et al.
Cancer Chemotherapy Reports|November 1, 1974
Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancerD L Ahmann, H F Bisel, R T Eagan, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reports|March 1, 1986
Phase II trial of diaziquone in malignant mesotheliomaR T Eagan, S Frytak, R L Richardson, et al.
American Journal of Clinical Oncology|February 1, 1987
Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trialR T Eagan, T M Therneau, J Rubin, et al.
Cancer Treatment Reports|October 1, 1987
Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancerR T Eagan, C Ruud, R E Lee, et al.
American Journal of Clinical Oncology|February 1, 1986
Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
Cancer Treatment Reports|August 1, 1982
Phase II study on DON in patients with previously treated advanced lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Cancer Treatment Reports|August 1, 1980
Early clinical trial of a 1-day intermittent schedule for pentamethylmelamineR T Eagan, E T Creagan, J Rubin, et al.
American Journal of Clinical Oncology|October 1, 1983
Preliminary communication--treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ;NSC-182986)R T Eagan, R P Dinapoli, R C Hermann, et al.
Cancer Chemotherapy Reports|March 1, 1975
Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanomaD L Ahmann, R G Hahn, H F Bisel, et al.
Cancer Treatment Reports|February 1, 1984
Carmustine and Baker's antifol combination chemotherapy for primary brain tumors progressive after irradiation and chemotherapyR T Eagan, R P Dinapoli, R C Hermann, et al.
Cancer Chemotherapy Reports|November 1, 1974
Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancerD L Ahmann, H F Bisel, R T Eagan, et al.
Pageof 11